Neurokappa Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Neurokappa Therapeutics General Information

Description

Developer of a biopharmaceutical drug designed to produce novel compounds targeting opioid receptors for neurological diseases. The company's platform develops proprietary medications for neurological diseases including stroke, pain, and addiction, enabling healthcare professionals to treat cerebral vasospasm.

Contact Information

Website
neurokor.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 3401 Grays Ferry Avenue
  • Philadelphia, PA 19146
  • United States
Primary Industry
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 3401 Grays Ferry Avenue
  • Philadelphia, PA 19146
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurokappa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 19-Aug-2026 Completed Out of Business
4. Accelerator/Incubator 27-Jan-2024 Completed Generating Revenue
3. Angel (individual) Cancelled Generating Revenue
2. Accelerator/Incubator 29-Jun-2016 Completed Generating Revenue
1. University Spin-Out 14-May-2015 Completed Generating Revenue
To view Neurokappa Therapeutics’s complete valuation and funding history, request access »

Neurokappa Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Pennsylvania University
To view Neurokappa Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Neurokappa Therapeutics FAQs

  • When was Neurokappa Therapeutics founded?

    Neurokappa Therapeutics was founded in 2015.

  • Where is Neurokappa Therapeutics headquartered?

    Neurokappa Therapeutics is headquartered in Philadelphia, PA.

  • What industry is Neurokappa Therapeutics in?

    Neurokappa Therapeutics’s primary industry is Pharmaceuticals.

  • Is Neurokappa Therapeutics a private or public company?

    Neurokappa Therapeutics is a Private company.

  • What is Neurokappa Therapeutics’s current revenue?

    The current revenue for Neurokappa Therapeutics is .

  • Who are Neurokappa Therapeutics’s investors?

    University of Pennsylvania has invested in Neurokappa Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process